查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1610269

照護現場- 2025-2030 年全球預測

Point of Care & Rapid Diagnostics Market by Platform (Dipstick, Immunoassay, Microfluidics), Sample (Blood, Urine), Purchase, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，照護現場和快速診斷市場估值為484.3億美元，預計到2024年將達到518.5億美元，複合年成長率為7.11%，到2030年將達到783.4億美元，預計將達到1000萬美元。

照護端 (POC) 和快速診斷包括在患者照護端或附近進行的醫學測試，並提供快速結果以促進立即臨床決策。對此類診斷的需求是由於需要及時診斷以減少患者等待時間並改善結果，特別是在緊急護理、農村地區和大流行期間。 POC 和快速診斷的應用範圍從血糖監測和妊娠檢測到 COVID-19 等感染疾病的高級分子診斷。最終使用領域包括醫院、診所、居家醫療環境和實驗室。市場成長是由技術進步、慢性病盛行率上升以及對醫療服務分散化的需求不斷增加所推動的。 COVID-19 大流行顯著擴大了對快速檢測解決方案的需求，並強調診斷速度是關鍵因素。機會在於擴大遠端醫療、將診斷與數位健康平台整合以及增強即時資料分析以更好地管理患者。然而，與基於實驗室的診斷相比，挑戰包括先進 POC 設備的高成本、監管限制以及可變的準確性。此外，設備互通性和資料整合等營運問題也阻礙了無縫採用。創新的關鍵領域包括開發多重測試設備、納入人工智慧以提高診斷準確性，以及開發攜帶式、易於使用的家用平台。市場是動態的，反映了向個人化護理和主動健康管理的轉變。尋求發展的公司應投資於研發合作，透過具有成本效益的解決方案使其產品組合多樣化，並優先對客戶進行關於 POC 診斷的好處和正確使用的教育。透過與醫療保健提供者的夥伴關係，擴大准入範圍並開拓開拓的地區，我們相信我們可以進一步加強我們的市場佔有率並推動永續成長。

主要市場統計
基準年[2023] 484.3億美元
預測年份 [2024] 518.5億美元
預測年份 [2030] 783.4億美元
複合年成長率（%） 7.11%

市場動態：針對快速發展的照護現場和快速診斷市場揭示的關鍵市場見解

供需的動態交互作用正在改變照護現場和快速診斷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 感染疾病迅速增加
    • 去中心化醫療保健系統的普及
    • 政府扶持政策
  • 市場限制因素
    • 對新型快速診斷檢測的認知較低且缺乏標準監管方法
  • 市場機會
    • 具有連接複用功能的創新 POC 測試
  • 市場挑戰
    • 實驗室有效診斷方法的替代方法

波特的五力：駕馭照護現場與快速診斷市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解照護現場和快速診斷市場的外部影響

外部宏觀環境因素在塑造照護現場和快速診斷市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解照護現場和快速診斷市場的競爭格局

對照護現場和快速診斷市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣照護現場與快速診斷市場供應商績效評估

FPNV 定位矩陣是評估照護現場和快速診斷市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了照護現場和快速診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，照護現場和快速診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病高發
      • 去中心化醫療保健系統的普及
      • 政府扶持政策
    • 抑制因素
      • 對新型快速診斷檢測的認知較低且缺乏標準監管方法
    • 機會
      • 具有連接複用功能的創新 POC 測試
    • 任務
      • 實驗室診斷的替代有效方法
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章照護現場和快速診斷市場：按平台

  • 量油尺
  • 免疫檢測
  • 微流體

第7章照護現場和快速診斷市場樣本

  • 血
  • 尿

第8章照護現場）

  • 在商店
  • 處方箋

第 9 章照護現場和快速診斷市場：按最終用戶分類

  • 居家護理
  • 醫院
  • 藥局

第10章美洲的照護現場與快速診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區照護現場與快速診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的照護現場和快速診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Binx Health, inc.
  • bioMerieux SA
  • Cardinal Health, Inc.
  • Co-Diagnostics, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Genomadix Inc.
  • Lucira Health, Inc.
  • Meridian Bioscience Inc. by SD Biosensor
  • Novartis AG
  • OraSure Technologies, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-742BD5183A2E

The Point of Care & Rapid Diagnostics Market was valued at USD 48.43 billion in 2023, expected to reach USD 51.85 billion in 2024, and is projected to grow at a CAGR of 7.11%, to USD 78.34 billion by 2030.

Point of Care (POC) and Rapid Diagnostics encompass medical testing conducted at or near the site of patient care, delivering quick results to facilitate immediate clinical decisions. The necessity for such diagnostics stems from the demand for timely diagnosis, especially in emergency care, rural settings, and during pandemics, to reduce patient wait times and improve outcomes. Applications of POC and rapid diagnostics range from glucose monitoring and pregnancy tests to advanced molecular diagnostics for infectious diseases like COVID-19. End-use sectors extend across hospitals, clinics, home care settings, and research laboratories. Market growth is fueled by technological advances, rising prevalence of chronic diseases, and an increasing demand for decentralizing healthcare services. The COVID-19 pandemic significantly expanded the need for rapid testing solutions, highlighting diagnostic speed as a pivotal factor. Opportunities lie in expanding telemedicine and integrating diagnostics with digital health platforms, enhancing real-time data analytics for better patient management. However, limitations such as the high cost of sophisticated POC devices, regulatory constraints, and variable accuracy compared to lab-based diagnostics pose challenges. Additionally, operational issues like device interoperability and data integration also hinder seamless adoption. Key areas for innovation include the development of multi-analyte testing devices, incorporating artificial intelligence for enhanced diagnostic accuracy, and advancing portable, user-friendly platforms for home use. The market is dynamic, reflecting a shift towards personalized care and proactive health management, demanding continuous innovation to address emerging healthcare needs. Companies looking to leverage growth should invest in R&D collaborations, diversify portfolio offerings with cost-effective solutions, and prioritize customer education on benefits and correct usage of POC diagnostics. Expanding access through partnerships with healthcare providers and exploring untapped regions would further cement market presence and drive sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 48.43 billion
Estimated Year [2024] USD 51.85 billion
Forecast Year [2030] USD 78.34 billion
CAGR (%) 7.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point of Care & Rapid Diagnostics Market

The Point of Care & Rapid Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High oprevelance of the infectious diseases
    • Proliferation of decentralized healthcare systems
    • Supportive government policies
  • Market Restraints
    • Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
  • Market Opportunities
    • Innovative POC test with multiplexing capabilities
  • Market Challenges
    • Alternate effective ways of diagnosis in laboratories

Porter's Five Forces: A Strategic Tool for Navigating the Point of Care & Rapid Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point of Care & Rapid Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point of Care & Rapid Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point of Care & Rapid Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point of Care & Rapid Diagnostics Market

A detailed market share analysis in the Point of Care & Rapid Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point of Care & Rapid Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point of Care & Rapid Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point of Care & Rapid Diagnostics Market

A strategic analysis of the Point of Care & Rapid Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point of Care & Rapid Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, inc., bioMerieux SA, Cardinal Health, Inc., Co-Diagnostics, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Genomadix Inc., Lucira Health, Inc., Meridian Bioscience Inc. by SD Biosensor, Novartis AG, OraSure Technologies, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Point of Care & Rapid Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Platform, market is studied across Dipstick, Immunoassay, and Microfluidics.
  • Based on Sample, market is studied across Blood and Urine.
  • Based on Purchase, market is studied across OTC and Prescription.
  • Based on End-User, market is studied across Homecare, Hospital, and Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High oprevelance of the infectious diseases
      • 5.1.1.2. Proliferation of decentralized healthcare systems
      • 5.1.1.3. Supportive government policies
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative POC test with multiplexing capabilities
    • 5.1.4. Challenges
      • 5.1.4.1. Alternate effective ways of diagnosis in laboratories
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Point of Care & Rapid Diagnostics Market, by Platform

  • 6.1. Introduction
  • 6.2. Dipstick
  • 6.3. Immunoassay
  • 6.4. Microfluidics

7. Point of Care & Rapid Diagnostics Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Urine

8. Point of Care & Rapid Diagnostics Market, by Purchase

  • 8.1. Introduction
  • 8.2. OTC
  • 8.3. Prescription

9. Point of Care & Rapid Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Homecare
  • 9.3. Hospital
  • 9.4. Pharmacy

10. Americas Point of Care & Rapid Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Point of Care & Rapid Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Point of Care & Rapid Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. Binx Health, inc.
  • 4. bioMerieux SA
  • 5. Cardinal Health, Inc.
  • 6. Co-Diagnostics, Inc.
  • 7. Danaher Corporation
  • 8. F. Hoffmann-La Roche AG
  • 9. Genomadix Inc.
  • 10. Lucira Health, Inc.
  • 11. Meridian Bioscience Inc. by SD Biosensor
  • 12. Novartis AG
  • 13. OraSure Technologies, Inc.
  • 14. Siemens Healthineers AG
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POINT OF CARE & RAPID DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIPSTICK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023